July 13, 2026 02:29 AM GMT Sino Biopharmaceutical | Asia Pacific M Update Risk Reward Update What's Changed Sino Biopharmaceutical (1177.HK) From To Bear Case HK$4.80 HK$4.50 Updated Components EPS Bull Base Bear Scenarios Risk Reward for Sino Biopharmaceutical (1177.HK) has been updated Reason for change Model adjustments ahead of 1H26 results. We keep innovative drug forecasts largely unchanged, while lowering generic+biosimilar sales forecasts amid the latest sales rep policies and upcoming VBP. We also ...